| # | % | |||||
|---|---|---|---|---|---|---|
| 201 | NEUROMETRIX INC | 3,060,197 | 612,000 | 0.03% | ||
| 202 | SERES THERAPEUTICS INC | 20,590 | 598,000 | 0.03% | ||
| 203 | ADMA BIOLOGICS, INC. | 100,000 | 595,000 | 0.03% | ||
| 204 | MIRATI THERAPEUTICS INC | 107,235 | 586,000 | 0.03% | ||
| 205 | Capnia, Inc. | 501,240 | 581,000 | 0.03% | ||
| 206 | RADIUS HEALTH INC | 157 | 577,000 | 0.03% | Call | |
| 207 | COMBIMATRIX CORP | 855,171 | 573,000 | 0.03% | ||
| 208 | ZAFGEN INC | 930 | 557,000 | 0.03% | Call | |
| 209 | ProQR Therapeutics NV | 110,000 | 532,000 | 0.03% | ||
| 210 | ANTHERA PHARMACEUTICALS INC | 1,677 | 518,000 | 0.03% | Call | |
| 211 | HEARTWARE INTERNATIONAL INC | 89 | 514,000 | 0.03% | Put | |
| 212 | NORTHWEST BIOTHERAPEUTICS | 881,585 | 512,000 | 0.03% | ||
| 213 | ASSEMBLY BIOSCIENCES INC | 90,362 | 502,000 | 0.03% | ||
| 214 | REVANCE THERAPEUTICS INC | 339 | 461,000 | 0.02% | Call | |
| 215 | ANTARES PHARMA INC | 424,100 | 445,000 | 0.02% | ||
| 216 | RADIUS HEALTH INC | 120 | 441,000 | 0.02% | Put | |
| 217 | BENITEC BIOPHARMA LTD | 345,576 | 438,000 | 0.02% | ||
| 218 | INSMED INC | 43,964 | 433,000 | 0.02% | ||
| 219 | BARCLAYS BK PLC | 300 | 414,000 | 0.02% | Call | |
| 220 | CANCER GENETICS | 199,580 | 397,000 | 0.02% | ||
| 221 | MINERVA NEUROSCIENCES INC COM | 38,000 | 388,000 | 0.02% | ||
| 222 | BIODELIVERY SCIENCES INTL IN | 1,626 | 384,000 | 0.02% | Call | |
| 223 | QUEST RESOURCE HOLDING CORP | 1,315,708 | 382,000 | 0.02% | ||
| 224 | RIGEL PHARMACEUTICALS INC | 1,684 | 375,000 | 0.02% | Call | |
| 225 | PARATEK PHARMACEUTICALS INC | 245 | 341,000 | 0.02% | Call | |
| 226 | MEDICINES CO | 100 | 336,000 | 0.02% | Put | |
| 227 | SUPERCONDUCTOR TECHNOLOGIES | 1,701,245 | 322,000 | 0.02% | ||
| 228 | NEWLINK GENETICS CORP COM | 28,261 | 318,000 | 0.02% | ||
| 229 | ANTHERA PHARMACEUTICALS I | 100,000 | 309,000 | 0.02% | ||
| 230 | CYNAPSUS THERAPEUTICS INC | 18,194 | 305,000 | 0.02% | ||
| 231 | SKYLINE MED INC | 1,957,037 | 298,000 | 0.02% | ||
| 232 | ACLARIS THERAPEUTICS INC COM | 15,812 | 292,000 | 0.02% | ||
| 233 | NEUROMETRIX INC | 172,236 | 286,000 | 0.01% | ||
| 234 | MEDIVATION INC | 45 | 271,000 | 0.01% | Put | |
| 235 | MEDIVATION INC | 4,500 | 271,000 | 0.01% | ||
| 236 | HISTOGENICS CORP | 150,630 | 258,000 | 0.01% | ||
| 237 | ACORDA THERAPEUTICS INC | 100 | 255,000 | 0.01% | Put | |
| 238 | AMARIN CORP PLC | 1,118 | 241,000 | 0.01% | Put | |
| 239 | MEDICINES CO | 7,000 | 235,000 | 0.01% | ||
| 240 | AKARI THERAPEUTICS PLC | 17,428 | 235,000 | 0.01% | ||
| 241 | ARBUTUS BIOPHARMA CORP | 669 | 233,000 | 0.01% | Call | |
| 242 | TENET HEALTHCARE CORP | 81 | 224,000 | 0.01% | Call | |
| 243 | CELLECTAR BIOSCIENCES INC | 230,013 | 219,000 | 0.01% | ||
| 244 | STAFFING 360 SOLUTIONS INC | 136,583 | 216,000 | 0.01% | ||
| 245 | RELYPSA INC | 115 | 213,000 | 0.01% | Call | |
| 246 | CIDARA THERAPEUTICS INC | 20,277 | 209,000 | 0.01% | ||
| 247 | ONCOBIOLOGICS INC - WARRANT A | 426,184 | 209,000 | 0.01% | ||
| 248 | ATHERSYS INC NEW | 91,746 | 199,000 | 0.01% | ||
| 249 | ONCOBIOLOGICS INC - WARRANT B | 436,923 | 196,000 | 0.01% | ||
| 250 | LIPOCINE INC NEW | 63,875 | 194,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-119067, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
